Ours partners
Since 2010, Lunginnov labs and offices are on the Campus de l’Institut Pasteur de Lille, in the heart of this well-known research institute. |
Collaborative research programs around endocan biomarkers are ungoing between INSERM U1019 and Lunginnov since the inception of the company. |
Lunginnov benefit of the support of Eurasanté, the agency specialised in the economic development of the health sector of the Lille Nord-Pas de Calais Region. |
The founders of Lunginnov were "laureates" of réseau ENTREPRENDRE NORD and from INNOTECH in 2009. |
|
|
Lunginnov is a member of Clubster Santé, the network of SME and companies in the field of health in Nord Pas de Calais (France). |
The CHRU (University Hospital of Lille) is a partner of Lunginnov involved in the clinical studies to validate endocan as a biomarker in diseases where endothelium gests challenged such as sepsis and hypervascularized cancers. |
Futurs Health Products, a dedicated agency for strategy, development and commercialization of health products that have been helping Lunginnov on collaborative research and development projects. Contact : This email address is being protected from spambots. You need JavaScript enabled to view it.. |
Lunginnov benefit of the support of the Pôle de Recherche et d’Enseignement Supérieur (PRES) in collaborative studies with R&D and technological transfert units. |
|
|
Financials partners
![]() |
Lunginnov benefit of financial supports from Banque Publique d’Investissement for the realization of research, transfert, innovative and development programs. |
![]() |
Autonomie et Solidarité : A capital risk company whose mission is creating and developing businesses to create jobs for the benefit of ethical and solidarity projects |
Nord France Amorçage aims to encourage the initiation and growth of new companies based on the optimization of technological innovation, services or uses, which are creative of wealth and jobs |